Trial ACE-536-LTFU-001

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

ACE-536-LTFU-001

Full title

A Phase 3b, open-label, single-arm, rollover study to evaluate long-term safety in subjects who have participated in other luspatercept (ACE-536) clinical Trials
Z-Nr: 371

NCT number

NCT04064060

Responsible organization

3. Med 3. Med Ismaninger Str. 22 81675 München Germany

Indications

Classification	Code	Description
-	-	Other trials

Trial design

Phase

III

Status

Recruitment finished

Votes

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Therapy

Zielgerichtet

Participants

	Function	Prename	Surname	Organization
	Responsible contact	Katharina	Götze	3. Med 3. Med Ismaninger Str. 22 81675 München Germany